SCHEMBL3506539

SCHEMBL3506539

C[C@@H]1CC[C@H]2C(C)(C)[C@H]3C[C@@]12CC[C@@]3(C)OC=O

nearest known ligand 0.64

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 2/20 0.64
▸ ALDH1A1 P00352 1/20 0.57
▸ LMNA P02545 1/20 0.57
▸ THRB P10828 1/20 0.57
▸ MAPK1 P28482 1/20 0.57
▸ CYP17A1 P05093 3/20 0.49
▸ CYP19A1 P11511 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14252530 1.00 ALOX15 (0.64) ALOX15ALDH1A1LMNATHRBMAPK1
SCHEMBL8737958 1.00 ALOX15 (0.64) ALOX15ALDH1A1LMNATHRBMAPK1
SCHEMBL14841540 0.81 ALOX15 (0.65) ALOX15ALDH1A1LMNATHRBMAPK1
SCHEMBL1773862 0.81 ALOX15 (0.65) ALOX15ALDH1A1LMNATHRBMAPK1
SCHEMBL19718040 0.81 ALOX15 (0.65) ALOX15ALDH1A1LMNATHRBMAPK1
SCHEMBL24534431 0.81 ALOX15 (0.65) ALOX15ALDH1A1LMNATHRBMAPK1
SCHEMBL18138230 0.81 ALOX15 (0.65) ALOX15ALDH1A1LMNATHRBMAPK1
SCHEMBL19718041 0.81 ALOX15 (0.65) ALOX15ALDH1A1LMNATHRBMAPK1
SCHEMBL17836881 0.81 ALOX15 (0.65) ALOX15ALDH1A1LMNATHRBMAPK1
SCHEMBL30250115 0.81 ALOX15 (0.65) ALOX15ALDH1A1LMNATHRBMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250212873-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-07-03 — — US claimed
EP-4482306-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-01-01 — — EP claimed
EP-4438065-A2 A MIXTURE COMPRISING 1,2-ALKANEDIOLS Symrise AG (DE) 2024-10-02 — — EP claimed
WO-2024175295-A1 DETERGENTS AND CLEANING AGENTS COMPRISING DISPERSIN AND FRAGRANCE HENKEL AG & CO. KGAA (DE) 2024-08-29 — — WO claimed
EP-4356894-A1 SUSTAINABLE PRODUCT WITH MALODORS Beiersdorf AG (DE) 2024-04-24 — — EP claimed
WO-2023192424-A1 VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-05 — — WO claimed
US-20230303953-A1 CLEANING COMPOSITIONS AND USES THEREOF HENKEL AG & CO. KGAA (DE) 2023-09-28 — — US claimed
EP-4179054-A1 CLEANING COMPOSITIONS AND USES THEREOF Henkel AG & Co. KGaA (DE) 2023-05-17 — — EP claimed
CN-115968399-A Cleaning composition and use thereof 汉高股份有限及两合公司 2023-04-14 — — CN claimed
EP-4210663-B1 LATE-STAGE PRODUCT DIFFERENTIATION PROCESS FOR PERSONAL CARE PRODUCTS PROCTER & GAMBLE (US) 2026-04-29 — — EP disclosed
EP-4682234-A1 LAUNDRY ADDITIVE INCLUDING PERFUME, BACTERIAL SPORES AND ENZYMES The Procter & Gamble Company (US) 2026-01-21 — — EP disclosed
US-20260015556-A1 LAUNDRY ADDITIVE INCLUDING PERFUME, BACTERIAL SPORES AND ENZYMES PROCTER & GAMBLE (US) 2026-01-15 — — US disclosed
EP-4299705-B1 A PROCESS FOR MAKING A COMPOSITION COMPRISING ALKYL POLYGLYCOSIDE AND PERFUME PROCTER & GAMBLE (US) 2025-12-17 — — EP disclosed
US-12410383-B2 Process of making a treatment composition that includes a plant rosin material and related premix compositions THE PROCTER & GAMBLE COMPANY (US) 2025-09-09 — — US disclosed
US-20130039962-A1 ENCAPSULATES ENCAPSYS, LLC 2013-02-14 — — US disclosed
WO-2013022949-A1 ENCAPSULATES THE PROCTER & GAMBLE COMPANY (US) 2013-02-14 — — WO disclosed
EP-2468239-A1 Encapsulates Procter & Gamble International Operations SA (CH) 2012-06-27 — — EP disclosed
US-20100248390-A1 COMPOSITIONS AND METHODS FOR IDENTIFYING LIGANDS OF ODORANT RECEPTORS DUKE UNIVERSITY (US) 2010-09-30 — — US disclosed
US-20080176780-A1 ENCAPSULATION OF BULKY FRAGRANCE MOLECULES TAKASAGO INTERNATIONAL CORPORATION (JP) 2008-07-24 — — US disclosed
EP-1894603-A1 Encapsulation of bulky fragrance molecules Takasago International Corporation (JP) 2008-03-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260015556-A1 LAUNDRY ADDITIVE INCLUDING PERFUME, BACTERIAL SPORES AND ENZYMES LPL, PLG, PNLIP ALOX15 275/4885ALDH1A1 58/4885LMNA 791/4885
US-20130039962-A1 ENCAPSULATES ABCB4, PPIB, FLNB ALOX15 433/4885ALDH1A1 696/4885LMNA 2056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback